Status: current, Sufficiently defined by necessary conditions definition status. Date: 28-Feb 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4955147011 | Valproate sodium 333 mg and valproic acid 145 mg prolonged-release oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4955148018 | Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4955149014 | Product containing precisely valproate sodium 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely valproate sodium 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | Prolonged-release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely valproate sodium 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely valproate sodium 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) | Plays role | Anticonvulsant therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely valproate sodium 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) | Has precise active ingredient | Valproic acid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely valproate sodium 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) | Has basis of strength substance | Valproic acid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely valproate sodium 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely valproate sodium 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely valproate sodium 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) | Has precise active ingredient | Valproate sodium | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely valproate sodium 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) | Has basis of strength substance | Valproate sodium | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely valproate sodium 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely valproate sodium 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely valproate sodium 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) | Is a | Product containing only valproic acid in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR